The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 6: Patient selection for pilot clinical trials of islet xenotransplantation

Xenotransplantation

Volumn 16, Issue 4, 2009, Pages 249-254

  O'Connell, Philip J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

End stage renal failure; Hypoglycemia unawareness; Islets of Langerhans; Type 1 diabetes; Xenotransplantation

Indexed keywords

ALLOTRANSPLANTATION; CLINICAL TRIAL; COMORBIDITY; CONSENSUS DEVELOPMENT; GLYCEMIC CONTROL; GRAFT RECIPIENT; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; PATIENT MONITORING; PATIENT SELECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; PATIENT SELECTION; SWINE; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 70349584375     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2009.0545.x     Document Type: Review

References (37)

1. Cozzi E, Tallacchini MC, Pierson RN, Sykes M, Vanderpool HY. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework. Xenotransplantation 2009 16 : 203 214.
2. Denner J, Schuurman HJ, Patience C. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation 2009 16 : 239 248.
3. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for the United States (US) and Non-US cases as Reported to the United Network for Organ Sharing (UNOSD) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005 19 : 433 455.
4. Sutherland DE, Gruessner AC, Carlson AM et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 2008 86 : 1799 1802.
5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000 342 : 381 389.
6. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999 22 : 99 111.
7. Jacobson AM, Musen G, Ryan CM et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007 356 : 1842 1852.
8. Leese GP, Wang J, Broomhall J et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003 26 : 1176 1180.
9. Pedersen-Bjergaard U, Pramming S, Heller SR et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004 20 : 479 486.
10. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007 50 : 1140 1147.
11. Tu E, Twigg SM, Duflou J, Semsarian C. Causes of death in young Australians with type 1 diabetes: a review of coronial postmortem examinations. Med J Aust 2008 188 : 699 702.
12. Tu E, Twigg SM, Semsarian C. Sudden death in type 1 diabetes: the mystery of the 'dead in bed' syndrome. Int J Cardiol 2008. [Epub ahead of print].
13. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008 57 : 3169 3176.
14. Skrivarhaug T, Bangstad HJ, Stene LC et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006 49 : 298 305.
15. Feltbower RG, Bodansky HJ, Patterson CC et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults. Diabetes Care 2008 31 : 922 926.
16. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238.
17. Ryan EA, Lakey JR, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001 50 : 710 719.
18. Pileggi A, Cobianchi L, Inverardi L, Ricordi C. Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach. Ann N Y Acad Sci 2006 1079 : 383 398.
19. Bromberg JS, Leroith D. Diabetes cure - is the glass half full? N Engl J Med 2006 355 : 1372 1374.
20. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355 : 1318 1330.
21. Cooper DKC, Tseng YL, Saidman SL. Alloantibody and xenoantibody cross-reactivity in transplantation. Transplantation 2004 77 : 1 5.
22. Campbell PM, Senior PA, Salam A et al. High risk of sensitization after failed islet transplantation. Am J Transplant 2007 7 : 2311 2317.
23. Sykes M, d'Apice A, Sandrin M, IXA Ethics Committee. Position paper of the Ethics Committee of the International Xenotransplantation Association. Xenotransplantation 2003 10 : 194 203.
24. Sykes M, Sandrin M, d'Apice A, Ethics Committee of the International Xenotransplantation Association. Guidelines for xenotransplantation. N Engl J Med 2003 349 : 1294 1295.
25. Becker BN, Odorico JS, Becker YT et al. Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol 2001 12 : 2517 2527.
26. Allen RD, Al-Harbi IS, Morris JG et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997 63 : 830 838.
27. Chow VC, Pai RP, Chapman JR et al. Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant 1999 13 : 356 362.
28. Nankivell BJ, Lau SG, Chapman JR et al. Progression of macrovascular disease after transplantation. Transplantation 2000 69 : 574 581.
29. Smets YF, Van Der Pijl JW, Ringers J, De Fijter JW, Lemkes HH. Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 1996 347 : 826 827.
30. Smets YF, Westendorp RG, Van Der Pijl JW et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999 353 : 1915 1919.
31. Rayhill SC, D'Alessandro AM, Odorico JS et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg 2000 231 : 417 423.
32. Fiorina P, Folli F, Maffi P et al. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 2003 75 : 1296 1301.
33. Vantyghem MC, Marcelli-Tourvielle S, Fermon C et al. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes. Transplantation 2009 87 : 66 71.
34. Cure P, Pileggi A, Froud T et al. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation 2008 85 : 801 812.
35. Bromberg JS, Kaplan B, Halloran PF, Robertson RP. The islet transplant experiment: time for a reassessment. Am J Transplant 2007 7 : 2217 2218.
36. Badet L, Benhamou PY, Wojtusciszyn A et al. Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial. Transplantation 2007 84 : 89 96.
37. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069.